Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Secretary's Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) has scheduled a public meeting. Information about CHAC and the meeting can be found on the CHAC website at https://www.cdc.gov/faca/committees/chachspt.html and the meeting website at https://targethiv.org/ta-org/chac.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 174 (Monday, September 11, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 174 (Monday, September 11, 2023)]
[Notices]
[Pages 62385-62386]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-19542]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's Centers for Disease Control and
Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and
[[Page 62386]]
STD Prevention and Treatment (CHAC) has scheduled a public meeting.
Information about CHAC and the meeting can be found on the CHAC website
at <a href="https://www.cdc.gov/faca/committees/chachspt.html">https://www.cdc.gov/faca/committees/chachspt.html</a> and the meeting
website at <a href="https://targethiv.org/ta-org/chac">https://targethiv.org/ta-org/chac</a>.
DATES: Tuesday, October 24, 2023, 9 a.m. to 4 p.m. Eastern Time (ET);
and Wednesday, October 25, 2023, 9 a.m. to 3 p.m. ET.
ADDRESSES: This meeting will be hybrid, held both virtually through
Zoom and in person at 5600 Fishers Lane, Pavilion Rooms 5A02, 5A03, and
5A04, Rockville, Maryland 20857. Advance registration is required to
attend. Please visit the meeting website to register. The in-person
registration deadline is Monday, October 16, 2023, at 5 p.m. ET;
registration for virtual attendance will remain open. Prior to the
meeting, each individual registrant will receive a registration
confirmation along with an access link to the virtual meeting location.
FOR FURTHER INFORMATION CONTACT: Shalonda Collins, Public Health
Analyst, HIV/AIDS Bureau, HRSA, (301) 945-0835;
<a href="/cdn-cgi/l/email-protection#8dcec5cccecce9fbe4fee2fff4cee2e0e0cde5fffeeca3eae2fb"><span class="__cf_email__" data-cfemail="6b28232a282a0f1d0218041912280406062b0319180a450c041d">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: CHAC provides advice and recommendations to
the Secretary of HHS (Secretary) on policy, program development, and
other matters of significance concerning the activities under Section
222 of the Public Health Service Act, 42 U.S.C. 217a.
The purpose of the CHAC is to advise the Secretary of HHS, CDC
Director, and HRSA Administrator regarding objectives, strategies,
policies, and priorities for the prevention and treatment of HIV, viral
hepatitis, and other STDs, including surveillance, epidemiologic,
behavioral, health services, and laboratory research, identification of
policy issues related to professional eduction, patient healthcare
delivery, and prevention services; agency policies regarding health
care delivery, research and training; strategic issues influencing the
ability of CDC and HRSA to fulfill their missions' programmatic efforts
to prevent and treat HIV, viral hepatitis, and other STDs; and support
to CDC and HRSA in their development of responses to emerging health
needs related to these issues.
During the October 24-25, 2023, meeting, CHAC will discuss issues
related to reducing barriers and improving outcomes in HIV and
Hepatitis C co-infection, payment models for addressing social
determinants of health, incorporating stigma reduction in HIV care and
treatment, as well as other special presentations. Agenda items are
subject to change as priorities dictate. Refer to the CHAC meeting
information page for any updated information concerning the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may also submit written statements as
further described below. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to CHAC should be sent
via the meeting website at <a href="https://targethiv.org/ta-org/chac">https://targethiv.org/ta-org/chac</a>. Requests
for oral comment must be received by October 17, 2023, at 5 p.m. ET to
be considered. Written comments may be submitted to Shalonda Collins at
the email address and/or phone number listed above prior to and up to
10 business days after the meeting. Visit the meeting information page
for additional details: <a href="https://targethiv.org/ta-org/chac">https://targethiv.org/ta-org/chac</a>.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Shalonda Collins at the
email address and/or phone number listed above at least 10 business
days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-19542 Filed 9-8-23; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.